Interleukin-27 suppresses experimental autoimmune encephalomyelitis during bone marrow stromal cell treatment
- 1 June 2008
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 30 (4), 222-229
- https://doi.org/10.1016/j.jaut.2007.10.001
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Balancing autoaggressive and protective T cell responsesJournal of Autoimmunity, 2007
- Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivitiesJournal of Autoimmunity, 2006
- Immunoregulatory function of mesenchymal stem cellsEuropean Journal of Immunology, 2006
- Transforming growth factor-β induces development of the TH17 lineageNature, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Jagged1 protein enhances the differentiation of mesenchymal stem cells into cardiomyocytesBiochemical and Biophysical Research Communications, 2006
- Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergyBlood, 2005
- Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathwayEuropean Journal of Immunology, 2005
- Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cellsBlood, 2005
- The Profile of Gene Expression of Human Marrow Mesenchymal Stem CellsThe International Journal of Cell Cloning, 2003